CIK 0001390478
- Non-accelerated filer
- Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-200-5278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $716,682
- in 3 filings
Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-03-13 | KRIEGSMAN STEVEN A Director | Sale | −900 | $3.33 | $3K | 146,425 |
| 2009-03-12 | KRIEGSMAN STEVEN A Director | Sale | −1,300 | $3.34 | $4K | 174,684 |
| 2009-03-11 | KRIEGSMAN STEVEN A Director | Sale | −2,700 | $3.44 | $9K | 175,984 |
| 2009-03-10 | KRIEGSMAN STEVEN A Director | Sale | −7,400 | $3.17 | $23K | 178,684 |
| 2009-03-09 | KRIEGSMAN STEVEN A Director | Sale | −4,500 | $2.97 | $13K | 186,084 |
| 2009-03-06 | KRIEGSMAN STEVEN A Director | Sale | −1,300 | $3.32 | $4K | 190,584 |
| 2009-03-05 | KRIEGSMAN STEVEN A Director | Sale | −2,100 | $3.36 | $7K | 191,884 |
| 2009-03-04 | KRIEGSMAN STEVEN A Director | Sale | −1,500 | $3.56 | $5K | 193,984 |
| 2009-03-03 | KRIEGSMAN STEVEN A Director | Sale | −2,900 | $3.64 | $11K | 195,484 |
| 2009-03-02 | KRIEGSMAN STEVEN A Director | Sale | −4,700 | $3.76 | $18K | 198,384 |
| 2009-02-27 | KRIEGSMAN STEVEN A Director | Sale | −1,300 | $4.05 | $5K | 203,084 |
| 2009-02-26 | KRIEGSMAN STEVEN A Director | Sale | −400 | $4.25 | $2K | 204,384 |
| 2009-02-25 | KRIEGSMAN STEVEN A Director | Sale | −1,800 | $4.25 | $8K | 204,784 |
| 2009-02-24 | KRIEGSMAN STEVEN A Director | Sale | −3,000 | $4.40 | $13K | 206,584 |
| 2009-02-09 | Hillsberg Sanford Director | Gift | −4,000 | 6,000 | ||
| 2009-01-15 | Samarsky Dmitry VP, Technology Development | Grant or award · Stock Option | +30,000 | 158,260 | ||
| 2009-01-15 | Woolf Tod President and CEO | Grant or award · Stock Option | +48,000 | 420,100 | ||
| 2009-01-15 | DiPalma Stephen J. CFO, EVP, Secretary | Grant or award · Stock Option | +47,000 | 166,428 | ||
| 2009-01-15 | DiPalma Stephen J. CFO, EVP, Secretary | Grant or award · Stock Option | +36,218 | 202,646 | ||
| 2009-01-15 | Andrikopoulos Konstantinos VP, Legal | Grant or award · Stock Option | +100,000 | 100,000 |
Page 28 of 29 · 580 trades